About Triple Point Biologics
Triple Point Biologics began in 1994 to provide reagents to study matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs). They produce antibodies and purified proteins for the research community to explore the role of MMPs and TIMPs in the wide range of normal and pathological conditions found in nature.
Triple Point Biologics was the first to provide several of these reagents, and strive to be your best resource for MMP and TIMP products. As the family of proteolytic enzymes and inhibitors expands, Triple Point Biologics grows to fulfill your research needs.
Look out for their new antibodies to calpain proteinases, and upcoming antibodies to the ADAMs proteinases and astacin proteinases.
Sectors
- antibodies
- proteins
- small molecules